IXHL (STOCKS)
Incannex Healthcare Limited American Depositary Shares
$0.271100
-0.007800 (-2.80%)
Prev close: $0.278900
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Joel Latham
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $94.17M
- Employees
- 12
- P/E (TTM)
- -0.25
- P/B (TTM)
- 1.26
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2025 (Q3)
|
$-7.97 | $-0.74 | -7.2274 | -978.53% |
|
Dec 2024 (Q2)
|
$-9.59 | $-0.69 | -8.8996 | -1,290.92% |
|
Sep 2024 (Q1)
|
$-10.83 | $-0.75 | -10.0827 | -1,352.84% |
Financial Statements
| Revenues | $12.00K |
| Nonoperating Income/Loss | -$23.54M |
| Operating Expenses | $24.34M |
| Depreciation and Amortization | $248.00K |
| Research and Development | $8.97M |
| Other Operating Expenses | $15.24M |
| Operating Income/Loss | -$24.33M |
| Income/Loss From Continuing Operations After Tax | -$47.87M |
| Income/Loss From Continuing Operations Before Tax | -$47.87M |
| Net Income/Loss | -$47.87M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$47.87M |
| Net Income/Loss Available To Common Stockholders, Basic | -$47.87M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.06 |
| Diluted Earnings Per Share | -$1.06 |
| Basic Average Shares | 363,782,026 |
| Diluted Average Shares | 363,782,026 |
| Assets | $78.72M |
| Current Assets | $78.30M |
| Noncurrent Assets | $425.00K |
| Fixed Assets | $168.00K |
| Other Non-current Assets | $257.00K |
| Liabilities | $1.71M |
| Current Liabilities | $1.65M |
| Wages | $52.00K |
| Other Current Liabilities | $1.60M |
| Noncurrent Liabilities | $64.00K |
| Equity | $77.01M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $77.01M |
| Liabilities And Equity | $78.72M |
| Net Cash Flow From Operating Activities | -$19.43M |
| Net Cash Flow From Operating Activities, Continuing | -$19.43M |
| Net Cash Flow From Investing Activities | -$2.30M |
| Net Cash Flow From Investing Activities, Continuing | -$2.30M |
| Net Cash Flow From Financing Activities | $88.63M |
| Net Cash Flow From Financing Activities, Continuing | $88.63M |
| Exchange Gains/Losses | $561.00K |
| Net Cash Flow | $69.65M |
| Net Cash Flow, Continuing | $69.09M |
| Comprehensive Income/Loss | -$47.78M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$47.78M |
| Other Comprehensive Income/Loss | -$47.78M |